LeonaBio Inc
LONA
69 hedge funds and large institutions have $484M invested in LeonaBio Inc in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 12 closing their positions.
493% more capital inflows, than outflows
Capital inflows: $123M | Capital outflows: $20.8M
80% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 15
4.68% more ownership
Funds ownership: 66.27% → 70.96% (+4.7%)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 70 → 69 (-1)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$32.5M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$17.8M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$14M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.77M |
| 5 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$9.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.6M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.42M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.13M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.85M |
| 5 |
Janus Henderson Group
London,
|
-$1.76M |
LONA Hedge Fund Activity: Q1 2021 in Review
69 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q1 2021, worth a combined $484M — down 34% from $734M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of LONA and 11 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 27 added.
The largest buyer was Franklin Resources, adding an estimated $32.5M. The largest seller was UBS Group, cutting an estimated $3.6M.
- 69 institutional investors held LeonaBio Inc (LONA) as of Q1 2021, down from 70 in Q4 2020.
- Funds reported $484M of LeonaBio Inc stock for Q1 2021, down 34% quarter-over-quarter.
- 11 funds opened new LeonaBio Inc positions in Q1 2021 and 12 closed out, a net change of -1 holder.
- The largest LeonaBio Inc buyer in Q1 2021 was Franklin Resources, an estimated $32.5M added.
- The largest LeonaBio Inc seller in Q1 2021 was UBS Group, an estimated $3.6M sold.
Based on aggregated 13F filings for Q1 2021.